Rognoni, C., Bertolani, A., & Jommi, C. (2018). Budget impact analysis of rituximab biosimilar in Italy from the hospital and payer perspectives. Global and Regional Health Technology Assessment, 5(1). https://doi.org/10.33393/grhta.2018.440